+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

Alpha 1 adrenergic receptor antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha 1 adrenergic receptor antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Amyloid precursor protein secretase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Amyloid precursor protein secretase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Nerve growth factor inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Nerve growth factor inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
ZANAFLEX Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

ZANAFLEX Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
KALYDECO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KALYDECO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
From
PEComa - Epidemiology Forecast - 2032 - Product Thumbnail Image

PEComa - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 58 Pages
  • Global
From
From
From
From
Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
Insomnia - Epidemiology Forecast - 2032 - Product Thumbnail Image

Insomnia - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 99 Pages
  • Global
From
From
Frontotemporal Dementia (FTD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Frontotemporal Dementia (FTD) - Epidemiology Forecast - 2032

  • Report
  • September 2022
  • 79 Pages
  • Global
From
Global Primary Mitochondrial Myopathies - Pipeline Insight, 2022 - Product Thumbnail Image

Global Primary Mitochondrial Myopathies - Pipeline Insight, 2022

  • Drug Pipelines
  • August 2022
  • 60 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more